Author:
Bode C.,Nordt T. K.,Runge M. S.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference56 articles.
1. AIMS Trial Study Group (1988) Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1:545–549
2. AIMS Trial Study Group (1990) Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet 335:427–431
3. Bleich SD, Nichols T, Schumacher R, Cooke D, Tate D, Steiner C, Brinkman D (1990) The role of heparin following coronary thrombolysis with tissue plasminogen activator (t-PA). Am J Cardiol 66:1412–1417
4. Bode C, Baumann H, von Hodenberg E, Freitag M, Nordt T (1993) Combinations of thrombolytic agents in acute myocardial infarction. Z Kardiol 82 [Suppl 2]:125–128
5. Bode C, Hudelmayer M, Mehwald P, Bauer S, Freitag M, von Hodenberg E, Newell JB, Kübler W, Haber E, Runge MS (1994) Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than untargeted hirudin. Circulation (in press)
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献